IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Aug. 18, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial...
Related Questions
How will the partnership and dispute resolution influence IQVIA and Veeva's revenue growth forecasts and earnings guidance?
What are the potential synergies and cost savings from the global clinical and commercial collaborations, and how might they affect each company's valuation multiples?
How does this alliance position IQVIA and Veeva relative to competitors in the health‑tech and life‑science SaaS markets, and could it lead to changes in market share or pricing power?